More on WHO DG elections www.thelancet.com/journals/lan...
@shaillygupta
Senior Communications Advisor, MSF Access Campaign. Avid follower of intellectual property and pro-access news. Believer of #ClaimingRightsNotCharity. Opinions are mine and doesn't represent my employer.
More on WHO DG elections www.thelancet.com/journals/lan...
MSF also issued a brief fact sheet in this regard few days ago: www.msf.org/report-near-...
A great tool to be used in remote settings for countries having limited resources. Hoping for a quicker roll out now. #TBSky
Tuberculosis funding cuts could cost households up to $80 billion www.cidrap.umn.edu/tuberculosis...
Read MSF's factsheet on emerging near point-of-care nucleic acid amplification tests (nPOC-NAATs) for TB. Watch out for more details on MiniDock Ultra (Pluslife), the first TB nPOC-NAAT test available for procurement through the Global Fund and the GDF. www.msf.org/report-near-...
Coming soon: Next round of WHO DG elections amid massive cuts and fund shortage: healthpolicy-watch.news/want-to-beco...
Different kind of yellow flowers in a green house garden in Geneva
Itβs spring already in a green house garden in Geneva
Worth noting for people following PABS discussions at Geneva level. There are attempts underway to roll back existing laws in Brazil that ensure broader post-trial access for clinical trial participants.
With foreign aid cuts continue to impact TB programs globally, there is a high risk that such recommendations that allow a better quality of life to people living with TB will slip even further down the priority list. Thanks to Stephanie Nolen for persistently spotlighting these field stories
WHO recommended community-based, out-patient treatment for people with drug resistant TB in 2011. Yet, 15 years after this recommendation and 8 years after the introduction of all-oral regimen, many countries are still slow in adopting this guidance. Must read by @stephanienolen.bsky.social
Of the 149 compulsory licenses that were pursued, 49 were not issued because companies responded. Of those, 23 were not issued after the pharmaceutical company offered to increase access through voluntary licensing, a price discount, or donations. Most often, discounts were offered.
The number of compulsory licenses pursued by wealthier nations rose from 15% of all such licenses between 2005 and 2014 to 54% between 2015 and 2024. In all, 149 such licenses were considered by any country - rich or poor - during that 20-year span, according to the study in BMJ Global Health.
The use of compulsory licenses by high-income countries to gain access to medicines increased considerably over a recent 10-year period, mostly for treatments of noncommunicable diseases such as cancer and cystic fibrosis, along with Covid-19, a new study found.
Modelling scientists at Wits University have calculated that if enough people β between 1-2 million per year β take LEN just once, new infections would decline fast enough so that South Africa can end #AIDS as a public health threat by 2043. #IDSky
One year later, MSF is witnessing the human cost of decisions that have upended aid programmes worldwide where #FundingCuts are restricting access to basic healthcare, vaccines, nutrition, epidemic control tools, and support for marginalised populations. www.doctorswithoutborders.org/latest/how-u...
Why is #insulin, an essential and lifesaving medication thatβs existed for over 100 years, still priced, patented, and distributed like a πluxury goodπ?
Listen as our advocacy advisor, Candice Sehoma, unpacks it on this #podcast episode: open.spotify.com/episode/6p39...
Few people have heard of Happi and Sabeti, yet they not only run a virus detection network to stop the next deadly pandemic but are also breaking down inequity between Africa and the global north by empowering African scientists to improve African lives. www.theguardian.com/global-devel...
CSOs continue to call for equitable access at every platform possible.
Message was loud and clear: Don't forget kids affected with tuberculosis! Nearly half of all children with TB are not diagnosed, which means they miss out on access to the lifesaving treatment.
Wow very very innovative protest!
At a session on TB in children, Aman Shukla from YOUNITE Global said that statistics will not change much in future if the community engagement continue to reduce in absence of funding and support #TBSky
Some good examples of countries providing TB treatment and care to refugees and migrants
Very impressive work being done by IOM to support people with TB on the move
Joanna Ladomirska from MSF presenting on TB in migrants. MSF supporting TB treatment and care in Poland to refugees from Ukraine managed to establish linkages and care in countries where these people moved. See map behind her.
Migrants and refugees are more vulnerable to TB and face barriers in accessing TB care and services #TBSky
John Green talks about economic injustice when it comes to tuberculosis. Progress is made but itβs not reaching to the people who most need it. #UnionConf #TBSky
« I thought I was the next one to go down after my best friend died of TB.Β Β» said Henry, TB survivor from Sierra Leone and protagonist of John Greenβs book Β΄Everything is TBβ. He is at the TB Union Conference today at the plenary sharing his experience of undergoing TB treatment.
watch here if you missed the session www.youtube.com/live/XBqQUT1...